{"id":"https://openalex.org/W2597670751","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e14004","title":"Development of algorithms for a quantitative real time-PCR assay to determine EGFRvIII status in glioblastoma patients from rindopepimut clinical trials.","display_name":"Development of algorithms for a quantitative real time-PCR assay to determine EGFRvIII status in glioblastoma patients from rindopepimut clinical trials.","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2597670751","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e14004","mag":"2597670751"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.e14004","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e14004","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.e14004","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111960889","display_name":"Jim S. Yan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801558778","display_name":"LabCorp (United States)","ror":"https://ror.org/03zsdhz84","country_code":"US","type":"company","lineage":["https://openalex.org/I2801558778"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jim Yan","raw_affiliation_strings":["LabCorp, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LabCorp, Durham, NC","institution_ids":["https://openalex.org/I2801558778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058971424","display_name":"Donald James Witt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801558778","display_name":"LabCorp (United States)","ror":"https://ror.org/03zsdhz84","country_code":"US","type":"company","lineage":["https://openalex.org/I2801558778"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald James Witt","raw_affiliation_strings":["LabCorp Clinical Trials, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LabCorp Clinical Trials, Durham, NC","institution_ids":["https://openalex.org/I2801558778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062886813","display_name":"Don Kafader","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801558778","display_name":"LabCorp (United States)","ror":"https://ror.org/03zsdhz84","country_code":"US","type":"company","lineage":["https://openalex.org/I2801558778"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Don Kafader","raw_affiliation_strings":["LabCorp, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LabCorp, Durham, NC","institution_ids":["https://openalex.org/I2801558778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037738700","display_name":"Alan Wookey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Wookey","raw_affiliation_strings":["Laboratory Corporation of America, Cranford, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Corporation of America, Cranford, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110684329","display_name":"Steve Anderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801558778","display_name":"LabCorp (United States)","ror":"https://ror.org/03zsdhz84","country_code":"US","type":"company","lineage":["https://openalex.org/I2801558778"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steve Anderson","raw_affiliation_strings":["LabCorp Clinical Trials, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LabCorp Clinical Trials, Durham, NC","institution_ids":["https://openalex.org/I2801558778"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Li Cai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Cai","raw_affiliation_strings":["Laboratory Corporation of America, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Corporation of America, Research Triangle Park, NC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037864594","display_name":"Marcia T. Eisenberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcia Eisenberg","raw_affiliation_strings":["Laboratory Corporation of America, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Corporation of America, Research Triangle Park, NC","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101653475","display_name":"Abdel B Halim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155447","display_name":"Celldex Therapeutics (United States)","ror":"https://ror.org/055923009","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155447"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdel Halim","raw_affiliation_strings":["Celldex Therapeutics, Hampton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celldex Therapeutics, Hampton, NJ","institution_ids":["https://openalex.org/I4210155447"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"e14004","last_page":"e14004"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9419000148773193,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9419000148773193,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11970","display_name":"Molecular Biology Techniques and Applications","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfrviii","display_name":"EGFRvIII","score":0.9819999933242798},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/egfr-mutation-status","display_name":"EGFR mutation status","score":0.578000009059906},{"id":"https://openalex.org/keywords/quantitative-real-time-pcr","display_name":"quantitative real-time PCR","score":0.7279999852180481},{"id":"https://openalex.org/keywords/partition-tree","display_name":"partition tree","score":0.5139999985694885},{"id":"https://openalex.org/keywords/support-vector-machine","display_name":"support vector machine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/predictive-modeling","display_name":"predictive modeling","score":0.6970000267028809},{"id":"https://openalex.org/keywords/biomarker-detection","display_name":"biomarker detection","score":0.550000011920929},{"id":"https://openalex.org/keywords/patient-stratification","display_name":"patient stratification","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6234187483787537},{"id":"https://openalex.org/C11413529","wikidata":"https://www.wikidata.org/wiki/Q8366","display_name":"Algorithm","level":1,"score":0.5536389350891113},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5384812951087952},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5044068098068237},{"id":"https://openalex.org/C76818968","wikidata":"https://www.wikidata.org/wiki/Q181940","display_name":"Sanger sequencing","level":4,"score":0.4988832473754883},{"id":"https://openalex.org/C42812","wikidata":"https://www.wikidata.org/wiki/Q1082910","display_name":"Partition (number theory)","level":2,"score":0.4308008551597595},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3574613034725189},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30911964178085327},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.28829196095466614},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22721272706985474},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.14597094058990479},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.12289535999298096},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11645364761352539},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08859094977378845},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08758378028869629},{"id":"https://openalex.org/C114614502","wikidata":"https://www.wikidata.org/wiki/Q76592","display_name":"Combinatorics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.e14004","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.e14004","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.e14004","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2139473501","https://openalex.org/W7096212198","https://openalex.org/W1934617888","https://openalex.org/W6901996829","https://openalex.org/W2052341898","https://openalex.org/W4285800402","https://openalex.org/W2795894536","https://openalex.org/W2991320624","https://openalex.org/W2762846408","https://openalex.org/W3195584766"],"abstract_inverted_index":{"e14004":[0],"Background:":[1],"The":[2,83,211],"Epidermal":[3],"growth":[4],"factor":[5],"receptor":[6],"variant":[7],"III":[8],"(EGFRvIII)":[9],"is":[10,27,70,223,236],"a":[11,18,131,216,279],"commonly":[12],"expressed":[13],"biomarker":[14],"in":[15,145,261,308,313],"glioblastoma":[16],"and":[17,53,63,80,88,140,178,194,199,205,232,250,271,278,284,303,310],"target":[19],"for":[20,29,32,55,91,191,196,202,207,238,318,322],"anti-EGFRvIII":[21],"therapeutic.":[22],"Determination":[23],"of":[24,57,60,101,105,133,188,220,230,257,288,306,316],"EGFRvIII":[25,94,307],"status":[26,76,95],"important":[28],"identifying":[30],"patients":[31,36,321],"the":[33,38,46,58,74,78,93,102,117,120,168,173,176,192,197,203,208,226,247,251,255,258,264,269,289,296,301,314],"treatment,":[34],"as":[35,127,142,158,160],"with":[37,130,185,244],"mutation":[39,75],"are":[40],"more":[41],"likely":[42],"to":[43,45,72,86,115,166,225,263,267,295,299],"respond":[44],"treatment.":[47],"A":[48,274],"qRT-PCR":[49,103],"assay":[50],"was":[51,85],"developed":[52,283],"validated":[54],"comparison":[56],"expression":[59],"EGFR":[61],"wildtype":[62],"vIII":[64],"mutant":[65],"forms.":[66],"However,":[67],"an":[68,161],"algorithm":[69,277],"needed":[71],"determine":[73],"using":[77,96],"Ct":[79,259,266],"delta":[81,217,265],"Ct.":[82],"goal":[84],"develop":[87,116],"evaluate":[89,167],"algorithms":[90,253,291],"determining":[92],"this":[97,234,245],"assay.":[98],"Methods:":[99],"Results":[100],"assays":[104],"~4,900":[106],"clinical":[107,111],"specimens":[108],"from":[109],"Rindopepimut":[110],"trials":[112],"were":[113,125,164,282],"used":[114,126,141],"algorithms.":[118],"From":[119],"test":[121,143],"results,":[122],"1763":[123],"samples":[124,134],"training":[128],"set,":[129],"subset":[132],"verified":[135],"by":[136],"bi-directional":[137],"Sanger":[138],"sequencing":[139],"set":[144],"predictive":[146,149],"modeling.":[147],"Nine":[148],"models":[150],"including":[151],"Support":[152],"Vector":[153],"Machine":[154],"(SVM),":[155],"Partition":[156,179,212,275],"Tree":[157,180,213,276],"well":[159],"existing":[162,297],"cut-off":[163,219,229,235,298],"tested":[165],"prediction":[169],"performance.":[170],"Results:":[171],"Among":[172],"nine":[174],"models,":[175],"SVM":[177,252,280],"algorithms,":[181],"demonstrated":[182],"best":[183],"performance":[184],"overall":[186],"accuracy":[187],"99.7%":[189],"(99.93%":[190],"positive":[193,204],"98.64%":[195],"negative)":[198,209],"99.2%":[200],"(99.87%":[201],"95.93%":[206],"respectively.":[210],"model":[214,281],"produced":[215],"CT":[218],"10.98":[221],"that":[222],"close":[224],"previously":[227],"established":[228],"11,":[231],"confirmed":[233],"sound":[237],"patient":[239],"sample":[240],"evaluations.":[241],"In":[242],"combination":[243],"cut-off,":[246],"partition":[248],"tree":[249],"allow":[254],"leverage":[256],"values":[260],"addition":[262],"increase":[268],"consistence":[270],"accuracy.":[272],"Conclusions:":[273],"tested.":[285],"Either":[286],"one":[287],"two":[290],"can":[292],"be":[293],"added":[294],"ensure":[300],"consistency":[302],"accurate":[304],"assessment":[305],"Glioblastoma,":[309],"may":[311],"aid":[312],"development":[315],"strategies":[317],"stratifying":[319],"Glioblastoma":[320],"EGFRvIII-directed":[323],"therapies.":[324],"Clinical":[325],"trial":[326],"information:":[327],"NCT00458601,":[328],"NCT01480479.":[329]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-07T00:00:00"}